At the same time, clinics in sub-Saharan Africa struggle to keep a single ultrasound machine running. Rural hospitals in South Asia lack basic diagnostic tools that could prevent maternal deaths. The gap between what the wealthiest health systems throw away and what the poorest ones desperately need is staggering — and it represents one of the most solvable injustices in modern healthcare.
Recycling, reusing, and refurbishing medical equipment isn't just an environmental talking point. It's an economic strategy, a public health intervention, and, increasingly, a moral obligation.
The Scale of the Problem
Healthcare is one of the most waste-intensive sectors on the planet. If the world's hospitals formed their own country, they would rank as the fourth-largest source of pollution globally. In the United States, the healthcare sector accounts for roughly eight percent of the nation's total greenhouse gas emissions. Single-use medical devices make up approximately 90 percent of device-related waste, and the vast majority of the plastics used in healthcare — around 91 percent — are never recycled.
The COVID-19 pandemic made all of this dramatically worse. At the peak of the crisis, global medical waste production surged to an estimated 29,000 tonnes per day. Developing nations saw waste volumes spike by as much as 425 percent. The mountains of discarded masks, gloves, gowns, and test kits exposed deep structural weaknesses in how the world manages healthcare waste — and underscored the urgent need for more circular approaches.
What Does It Mean to Recycle, Reuse, and Refurbish?
These three approaches, while related, serve different purposes in extending the life of medical equipment.
Recycling involves breaking down end-of-life devices into their raw materials — metals, plastics, glass, electronic components — and feeding those materials back into the manufacturing cycle. Around 90 percent of medical metal waste, including stainless steel tools and syringes, is already being recycled successfully. Plastics, however, lag far behind, with only about 12 percent of medical plastic waste being recovered.
Reuse means extending the active life of a device by using it again, either in the same facility or elsewhere. This applies both to durable equipment like wheelchairs and hospital beds, and to certain single-use devices that can be safely reprocessed. In the United States, over 8,000 hospitals already use reprocessed single-use devices — including 100 percent of the top-ranked hospitals in the U.S. News & World Report — saving 30 to 40 percent compared to purchasing new.
Refurbishment is the most comprehensive approach. It involves restoring used high-value equipment — MRI machines, CT scanners, X-ray systems, surgical robots — to a condition that meets original safety and performance standards. Major manufacturers like GE Healthcare, Siemens Healthineers, and Philips operate dedicated refurbishment programmes, offering restored equipment at 30 to 50 percent less than the cost of new devices.
The Benefits: Why This Matters
Bridging the Global Health Equity Gap
Perhaps the most powerful argument for medical equipment refurbishment is its potential to save lives in parts of the world where healthcare infrastructure is weakest. Approximately 85 percent of the global population lives in developing countries, yet these nations account for just 15 percent of the global medical equipment market. Only 19 percent of people in low-income and lower-middle-income countries have access to even the most basic diagnostic tests. The Lancet Commission has estimated that 1.1 million deaths in these countries could be prevented simply by improving diagnostics for six common conditions.
Refurbished equipment offers a direct path to closing that gap. A refurbished MRI machine that costs a fraction of a new one can transform diagnostic capabilities in a regional hospital that would otherwise have none at all. Donated and refurbished wheelchairs and mobility aids give individuals independence they could not afford otherwise.
Organizations like MATTER, a U.S.-based nonprofit, demonstrate the real-world impact of this approach. In 2024 alone, MATTER diverted 7.1 million pounds of medical equipment from landfills and redirected it to healthcare facilities in underserved communities around the world — and has kept over 25 million pounds out of landfills since 2019.
Economic Savings Across the Board
The financial case is compelling at every level. For hospitals in wealthy countries, recycling and reprocessing programmes cut procurement costs, reduce waste hauling fees, and can even generate tax benefits. One U.S. hospital system saved over $3.5 million in four years simply by switching from disposable to reusable surgical gowns.
For healthcare systems in developing countries, refurbished equipment is often the only realistic route to acquiring advanced technology. The global refurbished medical devices market reflects this demand — valued at roughly $19 billion in 2025, it is projected to grow to as much as $35 billion by the early 2030s, with the Asia-Pacific region seeing the fastest expansion.
Environmental Impact
The environmental benefits are equally significant. By recovering and reusing materials from medical devices, healthcare systems reduce demand for virgin raw materials, cut energy consumption in manufacturing, and keep hazardous materials out of landfills. Reusable personal protective equipment alone has been shown to reduce environmental impact by more than 60 percent compared to single-use alternatives.
With healthcare waste projected to reach 213 million tonnes of hazardous waste globally by 2030, circular approaches are not a luxury — they are a necessity.
The Struggles: Why Progress Has Been Slow
Despite the clear benefits, scaling up medical equipment reuse and refurbishment worldwide faces serious obstacles.
Regulatory Fragmentation
One of the biggest challenges is the lack of harmonised international standards for refurbished medical devices. Regulations vary dramatically from country to country. In the EU, the term "remanufacturing" has historically not even appeared in the medical device regulatory framework. The U.S. FDA defines remanufacturing broadly but in ways that don't always align with conventional industry definitions. Many developing countries have weak or nonexistent regulatory frameworks for refurbished devices, creating uncertainty for both buyers and sellers.
This patchwork of rules makes it difficult to build scalable, cross-border refurbishment supply chains. Some countries restrict or outright ban the import of refurbished medical equipment, even when it could dramatically improve local healthcare capacity.
Quality Perceptions and Trust
A persistent stigma surrounds refurbished medical equipment. Healthcare providers and patients alike sometimes question whether a refurbished device can truly perform as well as a new one. While OEM refurbishment programmes from major manufacturers come with rigorous quality guarantees, the market also includes non-OEM traders who may sell devices without adequate quality assurance — undermining trust for the entire sector.
Building confidence requires transparency, certification, and consistent standards — all of which are still evolving in many markets.
Infrastructure and Workforce Gaps
Even when refurbished equipment reaches developing countries, keeping it running is another challenge entirely. The WHO estimates that around 70 percent of medical equipment donated to developing countries from wealthier nations does not work in its destination hospitals. The reasons are painfully practical: lack of trained biomedical engineers, unavailability of spare parts, unreliable electricity, and equipment designed for climate-controlled environments that doesn't perform well in tropical heat and humidity.
Only 10 to 30 percent of donated medical equipment actually becomes operational in low- and middle-income countries. This means that well-intentioned donations can end up as waste themselves — compounding rather than solving the problem.
The Single-Use Culture
Healthcare has spent decades building systems around disposability. The shift toward single-use devices, driven by legitimate concerns about infection control, has become deeply embedded in clinical culture, procurement practices, and regulatory frameworks. Reversing that momentum — even where reuse is demonstrably safe — requires changing habits, rewriting policies, and overcoming institutional inertia.
Recent research has shown that reusable PPE and other reusable medical items can be just as safe as single-use alternatives when proper decontamination protocols are followed. But translating that evidence into widespread practice remains a work in progress.
The Path Forward
The good news is that momentum is building. Major manufacturers are investing in refurbishment infrastructure. Governments are beginning to incorporate circular economy principles into healthcare policy. The EU's upcoming Circular Economy Act, expected later this year, is likely to extend its reach into the medical device sector. And AI-driven quality assurance technologies are making it easier to certify refurbished devices to the highest standards.
But meaningful progress will require coordinated action across several fronts. International bodies like the WHO need to continue developing clear, practical guidelines for refurbished medical devices. Countries must harmonise their regulatory frameworks to enable safe, efficient cross-border trade in refurbished equipment. Donors and NGOs need to pair equipment donations with training, spare parts, and ongoing technical support. And healthcare systems everywhere need to start treating circularity not as an afterthought, but as a core operating principle.
The equation is simple. On one side, wealthy health systems generate millions of tonnes of medical waste, much of it still functional or recoverable. On the other, billions of people lack access to the most basic medical technology. Recycling, reusing, and refurbishing medical equipment is one of the most direct ways to address both problems at once — reducing environmental harm while extending the reach of lifesaving care to those who need it most.
The tools exist. The economics work. The question is whether we have the will to act at the scale the world demands.
This article is for informational purposes only and does not constitute medical, legal, or investment advice.